ACACB and obesity due to melanocortin 4 receptor deficiency: New models of whole body and skeletal muscle ACC2 deletion or pharmacological inhibition of ACC2, exhibited no protection from obesity and insulin resistance, while energy expenditure remained unaffected[25,26].